SEC Form 4 · accession 0001127602-19-010036
Medtronic plc · MDT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James T Lenehan
Director
Period of report
Mar 4, 2019
Accepted (ET)
Mar 5, 2019 · 6:36 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001613103
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Mar 4, 2019 | M | 2,671 | $29.96 | A | 51,808 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F2 | $29.96 | Mar 4, 2019 | M | 2,671 | D | — | Apr 27, 2019 | Ordinary Shares | 2,671 | 0 | D |
Explanation of responses
- F1This balance increased by 403 shares due to exempt transactions such as dividend reinvestment
- F2This option to purchase 2,671 New Medtronic ordinary shares for $29.96 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 2,671 Medtronic common stock shares for $29.96 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option.